# K.K. CYBO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/k-k-cybo

- Industry: Biotechnology
- Headquarters: Tokyo, Japan
- Website: www.cybo.jp
- Total disclosed funding: $3.4M
- Latest round: Series A (Jun 14, 2023)
- Investors on record: 2

## About

Based in Tokyo, Japan, established in 2018, K.K. CYBO manufactures and sells scientific instruments, software for research, reagents, and consumable goods. It also plans, designs, manufactures, and sells medical goods. It has jointly developed cell measurement equipment. K.K. CYBO has accepted research and development tasks. The company has also implemented, used, maintained, and managed intellectual property rights. In June 2023, K.K. CYBO raised JPY 400 million in series A funding from JAFCO Group, with participation from Incubate Fund.

K.K. CYBO carries out the development of scientific instruments, medical instruments and software in order to "know the cell deeply, and to use it widely". Its skill is technical development that makes use of high-speed imaging, which is its foundation technology, real-time AI, and high-speed manufacturing control. It develops ENMA, which is an innovative image cell sorter that analyzes cell images by AI and isolates them, and SHIGI, a cell scanner that analyzes cells in real-time AI using high-speed 3D images. It also develops ENMA, which is an innovative image cell sorter that analyzes cell images by AI and isolates them, and SHIGI, a cell scanner that analyzes cells in real-time AI using high-speed 3D images.   

The company plans to use the June 2023 funding to accelerate product development through the strengthening of engineer and human resource recruitment initiatives.

## Funding rounds

- Series A, Jun 14, 2023, $2.9M — JAFCO Group, Incubate Fund
- Seed, Mar 1, 2021, $0.6M — Incubate Fund

## Investors

- Incubate Fund (https://capitalatlas.ai/funds/incubate-fund) — Seed, Series A
- JAFCO Group (https://capitalatlas.ai/funds/jafco-group) — Series A